NAD+ for Anti-Aging: What the Science Actually Shows

Aging is not a single event. It is a cascade of interconnected cellular failures. And at the center of that cascade sits a molecule most people have never heard of: NAD+ (nicotinamide adenine dinucleotide).

NAD+ is a coenzyme present in every cell in your body. It is required for over 500 enzymatic reactions, including the ones that produce cellular energy, repair damaged DNA, regulate gene expression, and calibrate your circadian rhythm. When NAD+ is abundant, these systems function well. When it is depleted, they do not.

Here is the problem: NAD+ levels decline steadily with age. Massudi et al. (2012) published one of the first direct measurements of this decline in human tissue, demonstrating a progressive reduction in NAD+ in human skin samples across the lifespan. Zhu et al. (2015) confirmed the pattern in human brain tissue using in vivo magnetic resonance spectroscopy, finding significantly lower NAD+ concentrations in older adults compared to younger subjects. The consensus from multiple research groups is that by age 60, most people have roughly 50% of the NAD+ levels they had at age 20.

This is not a minor fluctuation. A 50% reduction in a molecule required for hundreds of critical enzymatic reactions means that the fundamental machinery of your cells is operating at half capacity. Mitochondria produce less ATP. DNA damage accumulates faster than it can be repaired. The genes that protect against inflammation and cellular stress become less active. The result is what we experience as aging: fatigue, cognitive decline, slower recovery, increased disease susceptibility.

Your DNA sustains tens of thousands of lesions every single day. Ultraviolet radiation, oxidative stress from normal metabolism, environmental toxins, and even the act of DNA replication itself all cause damage. Your cells are not defenseless against this. PARP enzymes (poly ADP-ribose polymerases), particularly PARP1 and PARP2, are the frontline repair system for single-strand DNA breaks, the most common type of DNA damage.

Like sirtuins, PARPs are NAD+-dependent. When PARP1 detects a DNA break, it uses NAD+ to synthesize poly ADP-ribose chains that recruit repair proteins to the damage site. This process is critical and it is expensive. PARP-mediated DNA repair is one of the largest consumers of cellular NAD+. Under conditions of heavy DNA damage (chronic inflammation, oxidative stress, environmental toxin exposure), PARPs can consume NAD+ faster than the cell can regenerate it.

This creates a destructive competition. PARPs and sirtuins are both drawing from the same finite NAD+ pool. When DNA damage increases with age and PARPs consume more NAD+ to handle the repair load, less NAD+ is available for sirtuin-mediated protective functions. The result is a vicious cycle: DNA damage increases NAD+ consumption, which reduces sirtuin activity, which impairs the protective processes (like mitochondrial maintenance and inflammation control) that would have prevented some of that DNA damage in the first place.

Accumulated unrepaired DNA damage is one of the nine recognized hallmarks of aging. It is also a primary driver of cancer risk. Maintaining adequate NAD+ levels ensures that PARPs can do their job without bankrupting the sirtuin budget. This is not theoretical. It is measurable biochemistry.

Telomeres are the protective caps on the ends of your chromosomes. They shorten with each cell division, and critically short telomeres trigger cellular senescence (permanent growth arrest) or apoptosis (programmed cell death). Telomere length is one of the most widely studied biomarkers of biological aging.

The connection between NAD+ and telomeres runs through the sirtuins. SIRT1 regulates the expression of telomerase reverse transcriptase (TERT), the enzyme responsible for rebuilding telomere length. When NAD+ is depleted and SIRT1 activity drops, TERT expression decreases and telomere maintenance suffers.

SIRT6 has an even more direct role. It physically associates with telomeric chromatin and deacetylates histone H3 at lysine 9 (H3K9), a modification essential for maintaining telomere structure and preventing dysfunction. Cells deficient in SIRT6 show accelerated telomere shortening, chromosomal fusions, and premature senescence. In mouse models, SIRT6 overexpression extends lifespan, partially through improved telomere maintenance.

This does not mean that NAD+ supplementation will regrow your telomeres. The relationship is about maintenance and protection, not reversal. Adequate NAD+ supports the sirtuin activity required to slow the rate of telomere attrition and reduce the dysfunctional signaling that comes from damaged telomeres. Combined with other longevity interventions like exercise (which independently activates telomerase) and reducing chronic inflammation, NAD+ optimization is one component of a telomere-protective strategy.

The internet is full of claims that NAD+ will reverse your biological age, cure neurodegeneration, and add decades to your lifespan. That is not what the evidence supports. Being honest about what NAD+ can and cannot do is important for patients making real decisions about real money.